https://technicality.me/2016/12/19/chart-review-sirtex-srx/
There is, it would seem, a happy ending for disgruntled shareholders of beleaguered health-care stock Sirtex.
After all the to-ing and fro-ing, the cash offer of $28 per share from global healthcare stock Varian Medical Systems, is a great outcome. Some investors may have doubled their money within the month.
Categories: Company review
Admedus – SIO to the rescue? 
Admedus’s ADAPT products gaining market traction. 
New Hills Facility opening at Seven Hills – Chart Review of HIL 
Hemp Seed Honey! Chart review of Eve Investments (EVE). 
Technically Speaking 
Leave a Reply